Universal Health Realty Income Trust

UHT remains entrenched in a Stage 4 decline, forming lower highs and lower lows beneath all key EMAs and the 200 SMA. Volume expands on down moves and rallies are consistently rejected at the 9/20 EMAs, confirming bearish structure and follow-through. Overbought context increases the risk of continued selling pressure, justifying immediate sell engagement. The primary risk is a support bounce at the 200 SMA that could temporarily stall downside execution.

• ↑Dividend of $0.75/share marks 39th straight annual increase.
• ↑Short interest dropped 53%, reflecting rising investor confidence.
• ↓FFO per share trending down despite EPS of $0.88 meeting expectations.